rs1884014
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005192.4(CDKN3):c.9+1168C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.238 in 152,206 control chromosomes in the GnomAD database, including 4,619 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.24 ( 4619 hom., cov: 33)
Consequence
CDKN3
NM_005192.4 intron
NM_005192.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.684
Publications
6 publications found
Genes affected
CDKN3 (HGNC:1791): (cyclin dependent kinase inhibitor 3) The protein encoded by this gene belongs to the dual specificity protein phosphatase family. It was identified as a cyclin-dependent kinase inhibitor, and has been shown to interact with, and dephosphorylate CDK2 kinase, thus prevent the activation of CDK2 kinase. This gene was reported to be deleted, mutated, or overexpressed in several kinds of cancers. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.364 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDKN3 | NM_005192.4 | c.9+1168C>G | intron_variant | Intron 1 of 7 | ENST00000335183.11 | NP_005183.2 | ||
CDKN3 | NM_001330173.2 | c.9+1168C>G | intron_variant | Intron 1 of 8 | NP_001317102.1 | |||
CDKN3 | NM_001130851.2 | c.9+1168C>G | intron_variant | Intron 1 of 6 | NP_001124323.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.239 AC: 36274AN: 152086Hom.: 4622 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
36274
AN:
152086
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.238 AC: 36300AN: 152206Hom.: 4619 Cov.: 33 AF XY: 0.240 AC XY: 17828AN XY: 74428 show subpopulations
GnomAD4 genome
AF:
AC:
36300
AN:
152206
Hom.:
Cov.:
33
AF XY:
AC XY:
17828
AN XY:
74428
show subpopulations
African (AFR)
AF:
AC:
11429
AN:
41504
American (AMR)
AF:
AC:
3583
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
579
AN:
3470
East Asian (EAS)
AF:
AC:
1962
AN:
5188
South Asian (SAS)
AF:
AC:
1624
AN:
4826
European-Finnish (FIN)
AF:
AC:
1728
AN:
10602
Middle Eastern (MID)
AF:
AC:
81
AN:
294
European-Non Finnish (NFE)
AF:
AC:
14649
AN:
68004
Other (OTH)
AF:
AC:
471
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1421
2842
4263
5684
7105
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1216
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.